Nanotechnology, renowned for its transformative potential, has become a crucial domain of interest within the UK’s scientific and technological spheres.
Guiding the nation’s commitment to this intricate field is the UK Research and Innovation (UKRI), operating under the auspices of the government’s Department for Business, Energy, and Industrial Strategy.
While the landscape of science and technology funding in the UK is constantly evolving, the Engineering and Physical Sciences Research Council (EPSRC) stands out as a major patron. A noteworthy portion of public funds for nanotechnology consistently comes through the EPSRC. Yet, it’s not the only game in town; the Medical Research Council (MRC) too has made a mark in this field.
Underlining this commitment to nanotechnology, academic institutions in the UK predominantly ride on the back of the EPSRC’s robust funding initiatives. But let’s not forget the role of the private sector. Beyond public funds, private sources have taken the torch in driving nanotechnology advancement in the country.
The year 2022 served as a testament to the UK’s dedication. The nation pumped roughly £29 million into graphene and carbon nanotechnology research. At the heart of this investment was the University of Manchester, globally acknowledged for its groundbreaking work in graphene.
Such investments serve a dual purpose. They not only spotlight Manchester as a hub of innovation but also underscore the UK’s unwavering commitment to spearheading transformative technologies. With such support, the horizon looks promising, with anticipated breakthroughs and a plethora of practical applications.
Taking a closer look at the EPSRC’s diverse portfolio, they extend their support to research in functional ceramics and inorganic materials, which fall under the vast umbrella of nanotechnology. This initiative is strategic. By fuelling research in these areas, the UK aspires to ignite novel developments in microelectronics, biomaterials, and material engineering. This vision is cemented with a hefty funding of around £68 million, shared amongst various UK-based academic institutions.
But the EPSRC doesn’t stop there. Another domain that’s catching their attention is polymer materials fused with nanotechnology. The goal? To amplify our understanding and usher in innovative applications of polymer materials like nanocomposites. And the results are palpable; on the global stage, the UK is emerging as a frontrunner, contributing significantly to pioneering research.
However, the EPSRC isn’t alone in this mission. The MRC, though not as frequent a patron, steps in when nanotechnology shows promise in revolutionizing healthcare. Within the MRC, the Molecular and Cellular Medicine Board (MCMB) takes the lead, particularly focusing on how nanotechnology can morph healthcare – from enhancing drug delivery mechanisms to unraveling the health implications tied to nanoparticles.
Rounding off the UK’s funding ecosystem are charities and non-governmental organizations. Though not directly linked to governmental entities, they play an instrumental role, especially when the endgame is leveraging nanotechnology to revolutionize healthcare.
Conclusion
The dedication of the UK to nanotechnology signals more than just an academic or economic pursuit; it represents an aspiration to harness the smallest of scales for some of the largest impacts. As we move forward, the interplay of science, industry, and policy in this domain will be pivotal. The choices made and the directions taken will shape not only the future of nanotechnology in the UK but also its influence and leadership on the global stage.
COMPANIES TO WATCH:
Silence Therapeutics, P2i, Oxford Instruments
Author:
Charlie Cragg
Content Producer and Writer
Nano Magazine | The Breakthrough
